India to Cambodia: Cefixime Export Trade Route
India has recorded 439 verified shipments of Cefixime exported to Cambodia, representing a combined trade value of $7.5M USD. This corridor is served by 134 active Indian exporters, with an average shipment value of $17.0K USD. The leading Indian exporter is GLOBEXIMS HEALTH CARE PRIVATE LIMITED, which accounts for 14% of total export value with 15 shipments worth $1.0M USD. On the buying side, M/S GLOHCARE PHARMA INC, is the largest importer in Cambodia with $947.7K USD in purchases. The top 3 suppliers — GLOBEXIMS HEALTH CARE PRIVATE LIMITED, UNOSOURCE PHARMA LIMITED, RAINBOW LIFE SCIENCES PRIVATE LIMITED — together control 29% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Cambodia Cefixime corridor is one of India's established pharmaceutical export routes, with 439 shipments documented worth a combined $7.5M USD. The route is dominated by GLOBEXIMS HEALTH CARE PRIVATE LIMITED, which alone accounts for roughly 14% of all export value, reflecting the consolidated nature of India's cefixime manufacturing sector.
Across 134 active suppliers, the average shipment value stands at $17.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with cefixime's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 32.5%, placing it at rank #19 among India's top cefixime export destinations globally.
On the import side, key buyers of Indian cefixime in Cambodia include M/S GLOHCARE PHARMA INC,, SAMRITH PHARMA CO., LTD., TELPHA INC., and 161 others. M/S GLOHCARE PHARMA INC, is the single largest importer with 2 shipments valued at $947.7K USD.
Route Characteristics
- Average transit
